We are live on
!
Find out more
Marshall Wace Portfolio holdings
AUM
$127B
1-Year Est. Return
46.06%
This Fund
S&P 500
This Quarter
Est. Return
+26.15%
1 Year Est. Return
+46.06%
3 Year Est. Return
+142.12%
5 Year Est. Return
+190.33%
10 Year Est. Return
+787.47%
AUM
$127B
AUM Growth
+$26.3B
(+26%)
Cap. Flow
+$9.28B
Cap. Flow
% of AUM
7.32%
Top 10 Holdings %
Top 10 Hldgs %
37.66%
Holding
3,898
New
771
Increased
1,083
Reduced
1,182
Closed
795
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$9.86B |
| 2 |
Costco
COST
|
+$907M |
| 3 |
AbbVie
ABBV
|
+$643M |
| 4 |
JPMorgan Chase
JPM
|
+$609M |
| 5 |
Bank of America
BAC
|
+$567M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$1.03B |
| 2 |
Mercado Libre
MELI
|
+$528M |
| 3 |
Broadcom
AVGO
|
+$514M |
| 4 |
SNDK
Sandisk
SNDK
|
+$507M |
| 5 |
Marvell Technology
MRVL
|
+$499M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 34.91% |
| 2 | Technology | 20.64% |
| 3 | Consumer Discretionary | 9.1% |
| 4 | Healthcare | 8.21% |
| 5 | Financials | 7.4% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2351
Appian
APPN
$2.48B
| $693K | ﹤0.01% |
30,245
+14,453
| +92% | +$321K |
|
2352
Gencor Industries
GENC
$278M
| $691K | ﹤0.01% |
46,305
-9,945
| -18% | -$147K |
|
2353
CALL
Zoom
ZM
$28.1B
| $690K | ﹤0.01% |
8,000
+7,400
| +1,233% | +$700K |
|
|
XZO
2354
Exzeo Group
XZO
$1.45B
| $690K | ﹤0.01% |
40,872
-147,579
| -78% | -$2.17M |
|
2355
Columbia Banking Systems
COLB
$8.56B
| $688K | ﹤0.01% |
21,481
-50,720
| -70% | -$1.51M |
|
|
XRN
2356
Chiron Real Estate Inc
XRN
$492M
| $688K | ﹤0.01% |
+18,344
| New | +$650K |
|
2357
Washington Trust Bancorp
WASH
$759M
| $688K | ﹤0.01% |
18,853
-7,497
| -28% | -$251K |
|
2358
Banc of California
BANC
$2.95B
| $687K | ﹤0.01% |
33,629
+1,156
| +4% | +$22K |
|
2359
Adicet Bio
ACET
$91.1M
| $687K | ﹤0.01% |
+79,488
| New | +$626K |
|
2360
ECARX Holdings
ECX
$397M
| $687K | ﹤0.01% |
532,342
-225,775
| -30% | -$257K |
|
2361
Kingstone Companies
KINS
$284M
| $682K | ﹤0.01% |
35,836
-143,805
| -80% | -$2.32M |
|
|
2362
CALL
Mercado Libre
MELI
$97.7B
| $679K | ﹤0.01% |
+400
| New | +$683K |
|
2363
FT Vest Technology Dividend Target Income ETF
TDVI
$578M
| $679K | ﹤0.01% |
+21,374
| New | +$661K |
|
2364
CALL
Ulta Beauty
ULTA
$23.5B
| $676K | ﹤0.01% |
+1,500
| New | +$762K |
|
2365
Nature's Sunshine
NATR
$243M
| $674K | ﹤0.01% |
+30,930
| New | +$722K |
|
2366
Ionis Pharmaceuticals
IONS
$9.42B
| $674K | ﹤0.01% |
8,501
-87,453
| -91% | -$6.58M |
|
2367
TScan Therapeutics
TCRX
$23.4M
| $674K | ﹤0.01% |
687,364
+450,018
| +190% | +$480K |
|
2368
BioLife Solutions
BLFS
$1.73B
| $669K | ﹤0.01% |
+23,692
| New | +$554K |
|
2369
Strawberry Fields REIT
STRW
$194M
| $669K | ﹤0.01% |
48,655
-12,856
| -21% | -$167K |
|
2370
Invesco Mortgage Capital
IVR
$773M
| $669K | ﹤0.01% |
+84,622
| New | +$682K |
|
|
NXDR
2371
Nextdoor Holdings
NXDR
$859M
| $666K | ﹤0.01% |
+293,603
| New | +$548K |
|
2372
CRA International
CRAI
$1.05B
| $664K | ﹤0.01% |
+4,669
| New | +$702K |
|
|
GLDG
2373
GoldMining Inc
GLDG
$230M
| $662K | ﹤0.01% |
727,096
-48,943
| -6% | -$54.8K |
|
2374
Hannon Armstrong Sustainable Infrastructure Capital
HASI
$5.06B
| $661K | ﹤0.01% |
+16,933
| New | +$677K |
|
2375
Caribou Biosciences
CRBU
$165M
| $661K | ﹤0.01% |
375,686
-829,982
| -69% | -$1.64M |
|
Similar funds
Marshall Wace's Q2 2026 Portfolio in Review
As of Q2 2026, Marshall Wace held 3,898 positions worth $127B, up 26% from $100B the previous quarter. Its ten largest holdings account for 38% of the portfolio.
Marshall Wace deployed $9.28B of net new capital in Q2 2026, opening 771 new positions and adding to 1,083 existing holdings. Its largest new stake was LPL Financial: 975,627 shares worth $275M.
By sector, the portfolio is most concentrated in Miscellaneous at 35% of assets, up from 30% a quarter earlier, followed by Technology and Consumer Discretionary.
On the sell side, the largest reduction was NVIDIA, an estimated $1.03B trimmed.
- Marshall Wace's largest Q2 2026 buy was LPL Financial: 975,627 shares worth $275M.
- Marshall Wace added most to iShares Core S&P 500 ETF in Q2 2026, an estimated $9.86B increase.
- Marshall Wace's biggest Q2 2026 reduction was NVIDIA, cutting an estimated $1.03B.
- Marshall Wace fully exited Merck in Q2 2026, selling an estimated $325M.
- Marshall Wace's ten largest holdings make up 38% of its $127B portfolio in Q2 2026.
- Marshall Wace opened 771 new positions and closed 795 in Q2 2026.
- Marshall Wace's portfolio value rose 26% quarter-over-quarter to $127B.
Based on Marshall Wace's 13F filing for Q2 2026, filed 13 Aug 2026.